Market Summery
The Infertility
Market Size is anticipated to grow at CAGR of 12.8 % and will reach a
valuation of USD 4.72 billion during the forecast period 2023-2032.
The
infertility market encompasses a wide range of products and services aimed at
addressing fertility issues faced by individuals and couples worldwide. With
infertility rates on the rise due to factors such as lifestyle changes, delayed
childbearing, and environmental factors, the market has witnessed significant
growth and innovation in recent years. Key segments within the infertility
market include assisted reproductive technology (ART) procedures such as in
vitro fertilization (IVF), fertility drugs, diagnostic tests, and fertility
preservation techniques.
Technological
advancements and increasing awareness about fertility options have fueled the
expansion of the infertility market, with a growing number of individuals
seeking solutions to conceive. IVF procedures, in particular, have emerged as a
popular choice for couples struggling with infertility, offering them the
possibility of parenthood through techniques like embryo transfer and
intracytoplasmic sperm injection (ICSI). Additionally, the market has seen a
rise in the availability of fertility clinics and specialized healthcare
providers offering a range of services tailored to meet the unique needs of
individuals and couples seeking fertility assistance. As the demand for
infertility treatments continues to grow, the market is expected to witness further
innovation and expansion in the coming years, driven by advancements in medical
technology and a growing emphasis on reproductive health and wellness.
The
infertility market is witnessing a significant surge in demand, driven by
various factors such as advancements in assisted reproductive
technology (ART) and the increasing prevalence of pregnancy
difficulties among couples worldwide. Assisted reproductive technology
encompasses a range of medical procedures designed to address infertility
issues and facilitate conception for couples facing challenges in conceiving
naturally. These technologies include in vitro fertilization (IVF),
intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer
(GIFT), among others. With the refinement of these techniques and the growing
expertise of fertility specialists, ART has become a cornerstone of modern
fertility treatments, offering hope to individuals and couples struggling with
infertility.
Market Outlook
Awareness
of the condition and preventive measures in terms of treatment is likely to
drive the market growth. Emergence of various clinics which can conduct tests
discreetly can bode well for the market. In addition, the recognition of
infertility as a disease by insurance organizations and coverage packages being
dispensed to patients is a sign of the large potential of the market.
Technological advances in terms of artificial reproduction technique (ART) and
artificial insemination are predicted to bolster the global infertility market
growth. Successful outcomes of such methods as well as conduction of clinical
trials for safe methods of conception among couples are other major drivers of
the market.
High
Infertility treatment costs, side effects of infertility treatment, and
societal taboos are factors which can impede market growth.
Competitive Outlook-
- SCSA Diagnostics, Inc.,
- Bayer Healthcare,
- EMD Serono, Inc.,
- Zydus Cadila Healthcare
Ltd,
- Aetna Inc.,
- Androvia LifeSciences,
- Andrology Solutions,
- Halotech DNA,
and
others are prominent names within the global infertility market
players.
Segmentation Analysis
The
global infertility market report is segmented by sex, diagnosis, drugs, and
techniques.
- By sex, it is
segmented into male, female, and unexplained.
- By diagnosis, it is segmented
infertility statistics worldwide into men diagnostic tests, female diagnostic
tests, and general diagnostic tests. Testicular biopsy, genetic testing,
semen analysis, and others are major sub-segments within the men
diagnostic tests segment. Female diagnostic tests, on the other hand, is
segmented into hysterosalpingography, hysteroscopy, laparoscopy, ovulation
testing, and others. Microscopic analysis, imaging, hormone testing,
genetic testing, and others are segments within general diagnostic tests.
- By drugs, it is
segmented into seraphine, clomiphene citrate, letrozole, hormone
treatment, and others.
- By techniques, it is
segmented into assisted reproductive technology (ART), surgery, and
intrauterine insemination. Surgery is further segmented into tubal
surgeries, laparoscopic or hysteroscopic surgery, and others.
Regional Analysis
North
America, Asia Pacific, Europe, and the Middle East & Africa (MEA) are the
regions being considered for the basis of the report.
North
America is predicted to dominate the market led by the U.S. Factors
facilitating regional market growth include rise in awareness levels of
patients, high expendable income levels of patients, and reimbursement schemes.
Europe
is expected to be the second largest region led by France, Germany, and the
U.K. Changes in lifestyles of patients and delayed pregnancies are factors
which can drive the need for fertility treatments. In addition, the successful
outcomes of fertility clinics as well as rise in cryopreservation can
contribute to the global infertility treatment in paris.
Industry News
- Seed funding to
accelerate research and development efforts put into fertility treatments
is expected to increase due to successful outcomes as well as demand for
affordable treatment methods. Recently, Mojo is planning to raise USD 1.8
million in capital with the help of Nordic firm, Inventure. The firm plans
to use robotics and artificial intelligence to assist in egg and sperm
quality analysis as well as develop methods to lower fertilization costs.
Related Reports-
Epilepsy Diagnosis and
Treatment
For more information, Please Visit us @ Market Research Future
